Hinge Bio
Clinical trials sponsored by Hinge Bio, explained in plain language.
-
New antibody aims to tame lupus by targeting immune cells
Disease control Recruiting nowThis early-stage study tests a new drug called HB2198 in about 30 adults with moderate-to-severe lupus, including kidney inflammation. The drug is designed to target and deplete certain immune cells (B cells) that drive the disease. The main goals are to check safety, find the ri…
Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New antibody tested in healthy people – no cure expected
Knowledge-focused Recruiting nowThis early-stage study tests the safety of a new drug called HB2198 in 32 healthy adults. Participants receive a single dose and are monitored for about two months. The goal is to see if the drug is safe and how the body processes it, not to treat any disease.
Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC